Caris Life Sciences (CAI) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $31.76, +4.97% vs the prior close of $30.25.
- Volume 3.55M shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CAI jumps 5.0% to $31.76. Closed at $31.76, +4.97% vs the prior close of $30.25. Day range $28.80–$32.15, opened at $29.50.
CAI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CAI jumps 5.0% to $31.76
- Closed at $31.76, +4.97% vs the prior close of $30.25. Day range $28.80–$32.15, opened at $29.50.
- Volume was 3.55M shares, 0.7x its 50-day average of 5.30M.
- Price is +18.2% vs its 50-day average ($26.86) and +49.3% vs its 200-day average ($21.27).
- 52-week range $14.19–$33.65; today's close sits at 90% of that range, 5.6% below the 52-week high.
Oct 14, 2026 — CAI rises 2.5% to $30.25
- Closed at $30.25, +2.46% vs the prior close of $29.53. Day range $29.02–$31.53, opened at $29.23.
- Volume was 4.35M shares, 0.8x its 50-day average of 5.31M.
- Price is +13.9% vs its 50-day average ($26.55) and +42.4% vs its 200-day average ($21.25).
- 52-week range $14.19–$33.65; today's close sits at 83% of that range, 10.1% below the 52-week high.
Oct 13, 2026 — CAI dips 0.5% to $29.53
- Closed at $29.53, -0.54% vs the prior close of $29.69. Day range $28.67–$29.78, opened at $29.48.
- Volume was 3.52M shares, 0.7x its 50-day average of 5.33M.
- Price is +12.4% vs its 50-day average ($26.27) and +39.0% vs its 200-day average ($21.24).
- 52-week range $14.19–$33.65; today's close sits at 79% of that range, 12.2% below the 52-week high.
Oct 12, 2026 — CAI ends flat (-0.0%) to $29.69
- Closed at $29.69, -0.03% vs the prior close of $29.70. Day range $28.49–$30.13, opened at $29.94.
- Volume was 5.00M shares, 0.9x its 50-day average of 5.30M.
- Price is +14.2% vs its 50-day average ($26.01) and +39.8% vs its 200-day average ($21.24).
- 52-week range $14.19–$33.65; today's close sits at 80% of that range, 11.8% below the 52-week high.
Oct 9, 2026 — CAI jumps 8.0% to $29.70
- Closed at $29.70, +8.00% vs the prior close of $27.50. Day range $27.67–$29.84, opened at $27.82.
- Volume was 5.03M shares, 1.0x its 50-day average of 5.29M.
- Price is +15.4% vs its 50-day average ($25.73) and +39.9% vs its 200-day average ($21.23).
- 52-week range $14.19–$33.65; today's close sits at 80% of that range, 11.7% below the 52-week high.
Oct 8, 2026 — CAI rises 1.5% to $27.50
- Closed at $27.50, +1.48% vs the prior close of $27.10. Day range $25.87–$27.61, opened at $26.75.
- Volume was 3.86M shares, 0.7x its 50-day average of 5.33M.
- Price is +8.0% vs its 50-day average ($25.45) and +29.6% vs its 200-day average ($21.22).
- 52-week range $14.19–$33.65; today's close sits at 68% of that range, 18.3% below the 52-week high.
Oct 7, 2026 — CAI dips 1.3% to $27.10
- Closed at $27.10, -1.29% vs the prior close of $27.45. Day range $26.07–$27.56, opened at $27.10.
- Volume was 4.88M shares, 0.9x its 50-day average of 5.30M.
- Price is +7.5% vs its 50-day average ($25.22) and +27.7% vs its 200-day average ($21.22).
- 52-week range $14.19–$33.65; today's close sits at 66% of that range, 19.5% below the 52-week high.
Oct 6, 2026 — CAI slides 9.7% to $27.45
- Closed at $27.45, -9.66% vs the prior close of $30.39. Day range $27.28–$32.56, opened at $30.69.
- Volume was 4.75M shares, 0.9x its 50-day average of 5.28M.
- Price is +9.9% vs its 50-day average ($24.99) and +29.3% vs its 200-day average ($21.23).
- 52-week range $14.19–$33.65; today's close sits at 68% of that range, 18.4% below the 52-week high.
Oct 5, 2026 — CAI jumps 7.4% to $30.39
- Closed at $30.39, +7.39% vs the prior close of $28.30. Day range $28.30–$30.46, opened at $28.30.
- Volume was 4.96M shares, 0.9x its 50-day average of 5.28M.
- Price is +22.8% vs its 50-day average ($24.75) and +43.2% vs its 200-day average ($21.23).
- 52-week range $14.19–$33.65; today's close sits at 83% of that range, 9.7% below the 52-week high.
Oct 2, 2026 — CAI ends flat (-0.2%) to $28.30, 6 down days in a row
- Closed at $28.30, -0.18% vs the prior close of $28.35. Day range $28.07–$28.97, opened at $28.72.
- Volume was 3.20M shares, 0.6x its 50-day average of 5.26M.
- Price is +15.7% vs its 50-day average ($24.45) and +33.4% vs its 200-day average ($21.21).
- 52-week range $14.19–$33.65; today's close sits at 72% of that range, 15.9% below the 52-week high.
- That makes 6 straight losses.
CAI latest news & SEC filings
Every SEC filing by or about CAI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 23, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Denton John Russel sold 7,500 shares at $31.82 (≈$238.63K) on Sep 22, 2026; now holds 174,855
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 17, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Brille Brian J converted options/RSUs into 400,000 shares at $2.44 (≈$976.00K) on Sep 17, 2026; now holds 630,303
- Brille Brian J sold 400,000 shares at $30.33 (≈$12.13M) on Sep 17, 2026; now holds 230,303
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 4, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Spetzler David Baxley sold 119,212 shares at $24.76 (≈$2.95M) on Sep 4, 2026
- Spetzler David Baxley sold 393,100 shares at $24.76 (≈$9.73M) on Sep 3, 2026
- Spetzler David Baxley sold 84,900 shares at $25.32 (≈$2.15M) on Sep 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 12, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $263.71M (prior year $181.40M) (+45.4% vs Jun 30, 2025)
- Net income: -$637.00K (prior year -$71.79M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: $0.00 (prior year -$7.97) (swung to profit vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade CAI
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.95% (largest 9.7%).
- Liquidity: about 4.91M shares (≈$155.91M) trade per day on average.
- 52-week position: $31.76 vs a range of $14.19–$33.65 (90% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 7 sales; latest: John Russel Denton sold 7,500 shares on Sep 22, 2026.
- Latest filings: 8-K Sep 14, 2026; 10-Q Aug 5, 2026; 8-K Aug 5, 2026.
- Share count: 282.60M shares outstanding (Aug 3, 2026), +0.5% vs a year earlier.
- Listing: Nasdaq · industry: Services-Medical Laboratories.
CAI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 29.50 | 32.15 | 28.80 | 31.76 | 3.55M |
| Oct 14, 2026 | 29.23 | 31.53 | 29.02 | 30.25 | 4.35M |
| Oct 13, 2026 | 29.48 | 29.78 | 28.67 | 29.53 | 3.52M |
| Oct 12, 2026 | 29.94 | 30.13 | 28.49 | 29.69 | 5.00M |
| Oct 9, 2026 | 27.82 | 29.84 | 27.67 | 29.70 | 5.03M |
| Oct 8, 2026 | 26.75 | 27.61 | 25.87 | 27.50 | 3.86M |
| Oct 7, 2026 | 27.10 | 27.56 | 26.07 | 27.10 | 4.88M |
| Oct 6, 2026 | 30.69 | 32.56 | 27.28 | 27.45 | 4.75M |
| Oct 5, 2026 | 28.30 | 30.46 | 28.30 | 30.39 | 4.96M |
| Oct 2, 2026 | 28.72 | 28.97 | 28.07 | 28.30 | 3.20M |
| Oct 1, 2026 | 30.60 | 30.96 | 28.29 | 28.35 | 4.41M |
| Sep 30, 2026 | 31.40 | 32.04 | 30.60 | 30.63 | 2.93M |
| Sep 29, 2026 | 31.64 | 32.33 | 30.82 | 31.55 | 3.71M |
| Sep 28, 2026 | 31.73 | 32.09 | 30.88 | 31.75 | 3.94M |
| Sep 25, 2026 | 32.65 | 32.77 | 31.58 | 31.98 | 2.92M |
| Sep 24, 2026 | 31.34 | 32.40 | 30.91 | 32.27 | 5.98M |
| Sep 23, 2026 | 31.12 | 32.89 | 31.10 | 31.65 | 4.36M |
| Sep 22, 2026 | 31.55 | 32.36 | 31.33 | 31.47 | 5.96M |
| Sep 21, 2026 | 30.23 | 30.71 | 29.97 | 30.65 | 6.14M |
| Sep 18, 2026 | 30.29 | 30.99 | 29.69 | 29.98 | 14.72M |
About Caris Life Sciences
Caris Life Sciences (CAI) is listed on the Nasdaq and classified by the SEC under “Services-Medical Laboratories”. Its business address is in IRVING, TX. State of incorporation: TX. Fiscal year ends December 31. SEC CIK 2019410.
CAI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Brian J Brille | See Remarks | Sep 17, 2026 |
| Peter M Castleman | Director | Aug 14, 2026 |
| David Paul Fredrickson | Director | Aug 14, 2026 |
| Joseph E Gilliam | Director | Aug 14, 2026 |
| David D Halbert | See Remarks | May 18, 2026 |
| Jon Halbert | Director | Aug 14, 2026 |
| Laura I Johansen | Director | Aug 14, 2026 |
| Jonathan Kenneth Charles Knowles | Director | Jun 2, 2026 |
| Lloyd Minor | Director | Aug 14, 2026 |
| T Danny Phillips | Director | Aug 14, 2026 |
| George Poste | Director | Jun 2, 2026 |
| Jeff L Vacirca | Director | Aug 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Brian J Brille | See Remarks | Sep 17, 2026 |
| John Russel Denton | See Remarks | Sep 23, 2026 |
| David D Halbert | See Remarks | May 18, 2026 |
| Luke Thomas Power | See Remarks | May 18, 2026 |
| David Baxley Spetzler | President | Sep 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 22, 2026 | John Russel Denton | Sale | 7,500 | $31.82 |
| Sep 17, 2026 | Brian J Brille | Sale | 400,000 | $30.33 |
| Sep 4, 2026 | David Baxley Spetzler | Sale | 119,212 | $24.76 |
| Sep 3, 2026 | David Baxley Spetzler | Sale | 393,100 | $24.76 |
| Sep 3, 2026 | David Baxley Spetzler | Sale | 84,900 | $25.32 |
| May 15, 2026 | Jon Halbert | Buy | 68,000 | $14.56 |
| May 11, 2026 | Jeff L Vacirca | Buy | 31,050 | $16.15 |
| Dec 11, 2025 | Luke Thomas Power | Sale | 1,400 | $27.16 |
| Dec 11, 2025 | Luke Thomas Power | Sale | 60,850 | $26.56 |
| Nov 7, 2025 | David Baxley Spetzler | Buy | 400 | $23.85 |
| Nov 7, 2025 | John Russel Denton | Buy | 4,184 | $24.09 |
CAI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $812.03M | $-68.09M | -3.22 | $83.16M |
| Dec 31, 2024 | $412.26M | $-281.89M | -10.66 | $-245.20M |
| Dec 31, 2023 | $306.13M | $-341.42M | -13.24 | $-276.10M |
Latest balance sheet: total assets $1.23B, total liabilities $637.89M, cash $819.90M (as of Jun 30, 2026).
CAI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $16.45 |
| May 7, 2026 | 8-K Item 2.02 (results) | $19.84 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $19.24 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $25.60 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $29.21 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $32.46 |
Related stocks · Services-Medical Laboratories
Natera (NTRA)Quest Diagnostics (DGX)Guardant Health (GH)Labcorp (LH)Celcuity (CELC)Grail (GRAL)CareDx (CDNA)Fortrea (FTRE)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CAI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.